Structure-Guided Design of Temporin-Derived Peptides Reveals Potent Dual-Mechanism Inhibitors of SARS-CoV-2.

Zannella, Carla et al.·Journal of medicinal chemistry·2026·
RPEP-165302026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Structure-Guided Design of Temporin-Derived Peptides Reveals Potent Dual-Mechanism Inhibitors of SARS-CoV-2.
Published In:
Journal of medicinal chemistry, 69(3), 3331-3342 (2026)
Database ID:
RPEP-16530

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-16530·https://rethinkpeptides.com/research/RPEP-16530

APA

Zannella, Carla; Fernandez, Feliciana Real; Santoro, Federica; Bellavita, Rosa; Casciaro, Bruno; Rovero, Paolo; Nencioni, Lucia; De Angelis, Marta; De Filippis, Anna; Galdiero, Massimiliano; Brancaccio, Diego; Merlino, Francesco; Grieco, Paolo; Mangoni, Maria Luisa; Carotenuto, Alfonso. (2026). Structure-Guided Design of Temporin-Derived Peptides Reveals Potent Dual-Mechanism Inhibitors of SARS-CoV-2.. Journal of medicinal chemistry, 69(3), 3331-3342. https://doi.org/10.1021/acs.jmedchem.5c03196

MLA

Zannella, Carla, et al. "Structure-Guided Design of Temporin-Derived Peptides Reveals Potent Dual-Mechanism Inhibitors of SARS-CoV-2.." Journal of medicinal chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.5c03196

RethinkPeptides

RethinkPeptides Research Database. "Structure-Guided Design of Temporin-Derived Peptides Reveals..." RPEP-16530. Retrieved from https://rethinkpeptides.com/research/zannella-2026-structureguided-design-of-temporinderived

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.